Jeff Yass’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $243M | Sell |
4,224,800
-610,200
| -13% | -$35M | 0.02% | 514 |
|
|
2026
Q1 | $293M | Sell |
4,835,000
-1,624,100
| -25% | -$94.7M | 0.03% | 391 |
|
|
2025
Q4 | $348M | Sell |
6,459,100
-1,203,800
| -16% | -$57.9M | 0.04% | 359 |
|
|
2025
Q3 | $346M | Sell |
7,662,900
-17,800
| -0.2% | -$831K | 0.04% | 366 |
|
|
2025
Q2 | $356M | Buy |
7,680,700
+641,500
| +9% | +$31.5M | 0.05% | 296 |
|
|
2025
Q1 | $429M | Buy |
7,039,200
+1,602,300
| +29% | +$93.4M | 0.07% | 206 |
|
|
2024
Q4 | $308M | Sell |
5,436,900
-1,295,200
| -19% | -$72.4M | 0.05% | 305 |
|
|
2024
Q3 | $348M | Sell |
6,732,100
-736,800
| -10% | -$34.6M | 0.06% | 263 |
|
|
2024
Q2 | $310M | Buy |
7,468,900
+2,105,300
| +39% | +$94.2M | 0.06% | 249 |
|
|
2024
Q1 | $291M | Buy |
5,363,600
+225,500
| +4% | +$11.5M | 0.05% | 299 |
|
|
2023
Q4 | $264M | Sell |
5,138,100
-532,200
| -9% | -$27.9M | 0.05% | 309 |
|
|
2023
Q3 | $329M | Buy |
5,670,300
+2,267,200
| +67% | +$139M | 0.07% | 224 |
|
|
2023
Q2 | $218M | Sell |
3,403,100
-924,600
| -21% | -$62M | 0.04% | 320 |
|
|
2023
Q1 | $300M | Buy |
4,327,700
+195,600
| +5% | +$13.8M | 0.06% | 249 |
|
|
2022
Q4 | $297M | Sell |
4,132,100
-256,300
| -6% | -$19.3M | 0.08% | 228 |
|
|
2022
Q3 | $312M | Sell |
4,388,400
-1,724,200
| -28% | -$125M | 0.08% | 184 |
|
|
2022
Q2 | $471M | Sell |
6,112,600
-28,500
| -0.5% | -$2.17M | 0.12% | 127 |
|
|
2022
Q1 | $448M | Buy |
6,141,100
+503,200
| +9% | +$33.8M | 0.08% | 183 |
|
|
2021
Q4 | $352M | Buy |
5,637,900
+655,300
| +13% | +$38.4M | 0.05% | 303 |
|
|
2021
Q3 | $295M | Sell |
4,982,600
-524,600
| -10% | -$34.5M | 0.04% | 377 |
|
|
2021
Q2 | $368M | Buy |
5,507,200
+790,200
| +17% | +$51.5M | 0.05% | 302 |
|
|
2021
Q1 | $298M | Sell |
4,717,000
-227,200
| -5% | -$14.1M | 0.05% | 330 |
|
|
2020
Q4 | $307M | Sell |
4,944,200
-384,200
| -7% | -$23.6M | 0.05% | 291 |
|
|
2020
Q3 | $321M | Sell |
5,328,400
-1,499,900
| -22% | -$90.3M | 0.06% | 239 |
|
|
2020
Q2 | $402M | Buy |
6,828,300
+259,100
| +4% | +$15.5M | 0.1% | 167 |
|
|
2020
Q1 | $366M | Buy |
6,569,200
+526,000
| +9% | +$32.1M | 0.12% | 137 |
|
|
2019
Q4 | $388M | Sell |
6,043,200
-1,729,300
| -22% | -$99M | 0.11% | 137 |
|
|
2019
Q3 | $394M | Buy |
7,772,500
+3,475,500
| +81% | +$163M | 0.13% | 122 |
|
|
2019
Q2 | $195M | Sell |
4,297,000
-1,882,700
| -30% | -$87.7M | 0.07% | 226 |
|
|
2019
Q1 | $295M | Buy |
6,179,700
+258,300
| +4% | +$12.9M | 0.12% | 133 |
|
|
2018
Q4 | $308M | Buy |
5,921,400
+430,100
| +8% | +$23.1M | 0.12% | 135 |
|
|
2018
Q3 | $341M | Sell |
5,491,300
-461,900
| -8% | -$27.4M | 0.11% | 135 |
|
|
2018
Q2 | $329M | Sell |
5,953,200
-1,025,200
| -15% | -$55.4M | 0.11% | 140 |
|
|
2018
Q1 | $441M | Sell |
6,978,400
-1,469,100
| -17% | -$94.5M | 0.16% | 87 |
|
|
2017
Q4 | $518M | Buy |
8,447,500
+800,900
| +10% | +$50.1M | 0.18% | 72 |
|
|
2017
Q3 | $487M | Buy |
7,646,600
+908,400
| +13% | +$53M | 0.19% | 77 |
|
|
2017
Q2 | $375M | Buy |
6,738,200
+514,300
| +8% | +$28M | 0.17% | 100 |
|
|
2017
Q1 | $338M | Buy |
6,223,900
+2,875,300
| +86% | +$158M | 0.17% | 95 |
|
|
2016
Q4 | $196M | Buy |
3,348,600
+712,400
| +27% | +$38.9M | 0.1% | 176 |
|
|
2016
Q3 | $142M | Sell |
2,636,200
-355,400
| -12% | -$22.8M | 0.07% | 239 |
|
|
2016
Q2 | $220M | Buy |
2,991,600
+186,300
| +7% | +$13.2M | 0.12% | 138 |
|
|
2016
Q1 | $179M | Buy |
2,805,300
+1,156,000
| +70% | +$72.9M | 0.1% | 168 |
|
|
2015
Q4 | $113M | Sell |
1,649,300
-1,690,600
| -51% | -$112M | 0.05% | 319 |
|
|
2015
Q3 | $198M | Buy |
3,339,900
+1,530,400
| +85% | +$97.1M | 0.09% | 201 |
|
|
2015
Q2 | $120M | Sell |
1,809,500
-508,900
| -22% | -$33.5M | 0.05% | 344 |
|
|
2015
Q1 | $150M | Sell |
2,318,400
-726,200
| -24% | -$45.5M | 0.07% | 253 |
|
|
2014
Q4 | $180M | Sell |
3,044,600
-767,900
| -20% | -$43.3M | 0.07% | 258 |
|
|
2014
Q3 | $195M | Buy |
3,812,500
+1,921,400
| +102% | +$96M | 0.08% | 222 |
|
|
2014
Q2 | $91.7M | Sell |
1,891,100
-1,708,200
| -47% | -$84.2M | 0.04% | 406 |
|
|
2014
Q1 | $187M | Buy |
3,599,300
+828,200
| +30% | +$44.1M | 0.09% | 193 |
|
|
2013
Q4 | $147M | Buy |
2,771,100
+30,800
| +1% | +$1.57M | 0.07% | 234 |
|
|
2013
Q3 | $127M | Buy |
2,740,300
+1,180,300
| +76% | +$51.8M | 0.07% | 244 |
|
|
2013
Q2 | $69.7M | Buy |
+1,560,000
| New | +$67.7M | 0.04% | 407 |
|
Other funds holding BMY
Jeff Yass's BMY Position: Q2 2026 in Review
Jeff Yass reduced its Bristol-Myers Squibb (BMY) stake by 69% in Q2 2026, selling an estimated $23.8M and leaving 185,612 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3293.
Jeff Yass first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $294M in Q4 2019. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Jeff Yass held 185,612 shares of Bristol-Myers Squibb worth $10.7M as of Q2 2026.
- Jeff Yass sold 415,277 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.8M.
- Bristol-Myers Squibb made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #3293 holding.
- Jeff Yass first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Jeff Yass's Bristol-Myers Squibb position peaked at $294M in Q4 2019.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.